$0.365
-0.008 (-2.12%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ELEV stock price ended at $0.37 on Tuesday, after losing -2.12%
Elevation Oncology Inc (ELEV) last closed at $0.365, losing -2.12%. These facts feed the 1-day and 1-week ELEV price prediction above.
Forecast Drivers
Elevation Oncology Inc (ELEV) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Seasonality analysis for ELEV
Historically the probability of a positive September return for ELEV is 20.00%. August offers the highest probability of a positive month at 100.00%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ELEV
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $0.32 | $0.38 | $0.39 | +3.67% |
| Oct 2026 | $0.37 | $0.38 | $0.39 | +2.97% |
| Nov 2026 | $0.29 | $0.33 | $0.38 | -8.30% |
| Dec 2026 | $0.38 | $0.44 | $0.47 | +19.79% |
In 2026, Elevation Oncology Inc (ELEV) is projected to range from $0.29 to $0.47.
Elevation Oncology Inc 2026 monthly forecast
In Sep 2026, Elevation Oncology Inc is projected to average $0.38, with a low of $0.32 and high of $0.39.
In Oct 2026, Elevation Oncology Inc is projected to average $0.38, with a low of $0.37 and high of $0.39.
In Nov 2026, Elevation Oncology Inc is projected to average $0.33, with a low of $0.29 and high of $0.38.
In Dec 2026, Elevation Oncology Inc is projected to average $0.44, with a low of $0.38 and high of $0.47.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.